SYNTHESIS AND BETA-ADRENERGIC PROPERTIES OF (E)-N-[3-(ALKYLAMINO)-2-HYDROXYPROPYLIDENE](METHYLOXY) AMINES SUBSTITUTED WITH AN AROMATIC GROUP ON THEIR [(METHYLOXY)IMINO] METHYL MOIETY (MOIMM) - AN INVESTIGATION INTO THE BIOPHARMACOLOGICAL EFFECTS OF AN ARYL SUBSTITUTION IN THE CLASS OF MOIM BETA-BLOCKING DRUGS

被引:15
|
作者
BALSAMO, A
BRESCHI, MC
CHIELINI, G
FAVERO, L
MACCHIA, M
MARTINELLI, A
MARTINI, C
ROSSELLO, A
SCATIZZI, R
机构
[1] UNIV PISA,IST POLICATTEDRA DISCIPLINE BIOL,I-56126 PISA,ITALY
[2] UNIV PISA,DIPARTIMENTO CHIM BIOORGAN,I-56126 PISA,ITALY
关键词
ADRENERGIC DRUG; BETA-BLOCKING AGENT; (METHOLOXY)IMINO]METHYL MOIETY; (E)-N-[3-(AMINO)-2-HYDROXYPROPYLIDENE](ARYLMETHYLOXY)AMINE;
D O I
10.1016/0223-5234(96)88293-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
N-Isopropyl-(5a-g) and N-t-butyl-substituted(6a-g) (E)-N-[3-(amino)-2-hydroxypropylidene](arylmethyloxy)amines, which present an aromatic ring (Ar) linked to the CH2 carbon of the [(methyloxy)imino]methyl moiety (MOIMM), were synthesized with the aim of comparing their beta-adrenergic properties with those of the previously studied completely aliphatic analogs 1,2 and 3,4. Compounds 5 and 6 were tested for their affinity towards beta(1)- and beta(2)-adrenoceptors by radioligand binding experiments; the compounds with the highest affinity were also assayed for their beta(1) and beta(2)-adrenergic activity by functional tests on isolated preparations. The biopharmacological results show that, for the MOIM derivatives studied (1-6), the presence of an Ar substituent linked to the MOIM, as in 5 and 6, does not have any appreciable effect on the beta(1)-adrenergic properties in terms of affinity and activity; this type of substituent, on the contrary, appears to be capable of improving the beta(2)-adrenergic properties, as far as the receptor affinity is concerned. These results are discussed on the basis of a comparison of the conformational and electronic characteristics.
引用
收藏
页码:743 / 755
页数:13
相关论文
共 2 条
  • [1] Synthesis and β-adrenergic properties of (Z)-N-[3-(alkylamino)-2-hydroxypropylidene](aryl-methyloxy)amines:: Effects of the configuration around the methyloxyiminomethyl (MOIM) double bond on the biopharmacological properties of MOIM-type β-blocking agents
    Balsamo, A
    Breschi, MC
    Chiellini, G
    Lapucci, A
    Lazzeri, N
    Macchia, M
    Martinelli, A
    Micali, E
    Nencetti, S
    Rossello, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (11) : 2151 - 2160
  • [2] New chiral methyloxyiminomethyl(MOIM) beta-adrenergic antagonists. (S)- and (R)-N-[3-(alkylamino)-2-hydroxypropylidene](p-chlorophenylmethyloxy)amines as probes for determining enantiomeric specificity in the class of MOIM-type beta-adrenergic blocking agents
    Balsamo, A
    Breschi, MC
    Chiellini, G
    Macchia, B
    Macchia, M
    Manera, C
    Sacca, P
    Scatizzi, R
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (03) : 199 - 206